Patents by Inventor In-koo Kim
In-koo Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240141530Abstract: A method for producing a copper composite structure is disclosed. The method for producing a copper composite structure includes a first step of forming a copper pillar structure; and a second step of annealing the copper pillar structure under a nitrogen atmosphere.Type: ApplicationFiled: March 8, 2022Publication date: May 2, 2024Applicant: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Chang-Koo KIM, Jun-Hyun KIM, Sanghyun YOU
-
Patent number: 11962791Abstract: Provided are an inter prediction method and a motion compensation method. The inter prediction method includes: performing inter prediction on a current image by using a long-term reference image stored in a decoded picture buffer; determining residual data and a motion vector of the current image generated via the inter prediction; and determining least significant bit (LSB) information as a long-term reference index indicating the long-term reference image by dividing picture order count (POC) information of the long-term reference image into most significant bit (MSB) information and the LSB information.Type: GrantFiled: November 19, 2021Date of Patent: April 16, 2024Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Young-o Park, Il-koo Kim, Chan-yul Kim, Kwang-pyo Choi
-
Publication number: 20240119890Abstract: A display device includes a sub-pixel connected to a scan write line, a first data line, and a second data line. The sub-pixel includes a light emitting element, a first pixel driving unit configured to generate a control current according to a first data voltage of the first data line, a second pixel driving unit configured to generate a driving current applied to the light emitting element according to a second data voltage of the second data line, and a third pixel driving unit configured to apply the driving current to the light emitting element according to the control current of the first pixel driving unit. The first pixel driving unit includes a first transistor to generate the control current according to the first data voltage, a second transistor configured to apply the first data voltage of the first data line to a first electrode of the first transistor.Type: ApplicationFiled: September 6, 2023Publication date: April 11, 2024Inventors: Nak Cho CHOI, Jeong Su KIM, Myung Koo HUR
-
Publication number: 20240083415Abstract: An advanced driver assistance system (ADAS) includes a communicator configured to communicate with a camera; and a processor configured to: receive a first image and a second image obtained by the camera, obtain a plurality of first feature points based on the received first image, obtain a plurality of second feature points based on the received second image, obtain a plurality of first and second feature points matching each other among the plurality of first feature points and the plurality of second feature points, obtain an optical flow and a vanishing point based on the plurality of first and second feature points matching each other, recognize a pose of the camera based on the optical flow and the vanishing point, and correct a distance to an object in the second image based on the recognized pose of the camera.Type: ApplicationFiled: May 22, 2023Publication date: March 14, 2024Applicants: Hyundai Motor Company, Kia CorporationInventors: Jung Hyun LEE, Sam Yong KIM, Donghoon KOO
-
Publication number: 20240080449Abstract: A method of determining a reference picture set (RPS), which is a set of reference pictures used in predictive decoding of a current picture that is to be decoded includes: obtaining a flag indicating whether the RPS is determined based on POC values of the current picture and a previous picture or whether the RPS is determined based on an index of a reference RPS, which is an identification value of the reference RPS that is one of pre-defined RPSs and is referred to in determining the RPS, and a delta RPS that is a difference value between a POC vale of a reference picture included in the reference RPS and a POC value of a reference picture included in the RPS; and determining the RPS according to a value of the flag.Type: ApplicationFiled: November 10, 2023Publication date: March 7, 2024Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: Il-koo KIM, Young-o Park
-
Patent number: 11923562Abstract: A battery module includes: a battery cell assembly having a plurality of battery cells; a top plate configured to cover an upper side of the battery cell assembly; a bottom plate configured to cover a lower side of the battery cell assembly; a sensing assembly disposed to cover a front side and a rear side of the battery cell assembly; a pair of side plates disposed at side surfaces, respectively, of the battery cell assembly; and a pair of compression pads disposed between the pair of side plates and the battery cell assembly, respectively.Type: GrantFiled: November 1, 2022Date of Patent: March 5, 2024Assignee: LG Energy Solution, Ltd.Inventors: Sung-Won Seo, Dong Yeon Kim, Ho-June Chi, Dal-Mo Kang, Jin-Hak Kong, Jeong-O Mun, Yoon-Koo Lee, Yong-Seok Choi, Alexander Eichhorn, Andreas Track
-
Publication number: 20240047731Abstract: A lithium secondary battery includes a positive electrode, a negative electrode, a separator, and an electrolyte, wherein the positive electrode includes a positive electrode active material layer having a positive electrode active material containing an overlithiated manganese-based oxide represented by Formula 1 below, and the negative electrode includes a negative electrode active material layer having a silicon-based negative electrode active material, LiaNibCocMndMeO2 ??[Formula 1] wherein, M is at least one selected from the group consisting of Al, B, Co, W, Mg, V, Ti, Zn, Ga, In, Ru, Nb, Sn, Sr, and Zr, and 1<a, 0?b?0.5, 0?c?0.1, 0.5?d<1.0, and 0?e?0.2, and. Preferably, in the Formula 1, 1.1?a?1.5, 0.1?b?0.4, 0?c?0.05, 0.5?d?0.80, and 0?e?0.1.Type: ApplicationFiled: July 21, 2022Publication date: February 8, 2024Applicant: LG Energy Solution, Ltd.Inventors: Byung Chun Park, Yo Han Kwon, Je Young Kim, Seok Koo Kim, Wang Mo Jung, Yong Ju Lee, Chul Haeng Lee
-
Publication number: 20240034790Abstract: The present invention relates to an antibody specific for CD47 and uses thereof, and more particularly, to an antibody that specifically binds to CD47, a chimeric antigen receptor comprising the antibody, and a pharmaceutical composition comprising the same for preventing or treating diseases mediated by CD47-expressing cells. In the present invention, antibodies that more specifically binds to CD47 were screened to establish 7 new types of antibodies (7C7, 5H4, 5A4, 4E12, 3H3, 3A5, 1E7), and it was confirm that the novel antibodies can specifically binds with CD47 antigen. In addition, since it was confirmed that the production of a chimeric antigen receptor (CAR) targeting CD47 is possible using the established antibody, the CD47-specific antibody of the present invention and the chimeric antigen receptor prepared using the same can be applied for use in preventing or treating a cancer or tumor expressing CD47.Type: ApplicationFiled: December 7, 2021Publication date: February 1, 2024Applicant: INNOBATION BIO., LTD.Inventors: Ki Tae KIM, Seung Koo KIM
-
Patent number: 11883509Abstract: The present disclosure relates to a method for providing information for determining lung tumor through inhalation of a fluorescent contrast agent, more particularly to a method of inhaling a small amount of Indocyanine green. The present disclosure does not have the problem of the existing intravenous injection that the administered fluorescent contrast agent is distributed throughout the body. In addition, when comparing the cancer detection efficiency of inhalation administration and intravenous injection, the inhaled fluorescent contrast agent exhibits remarkably higher cancer detection effect than the intravenously injected fluorescent contrast agent.Type: GrantFiled: September 5, 2019Date of Patent: January 30, 2024Assignees: Korea University Research and Business Foundation, Korea Advanced Institute Of Science And TechnologyInventors: Hyun Koo Kim, Yuhua Quan, Byeong-Hyeon Choi, Ji-Yun Rho, Ji Ho Park, Ji Young Lim, Chan Hee Oh, Daeho Jung
-
Publication number: 20240023910Abstract: The present invention relates to an X-ray imaging device for minimally invasive surgery, the device including: a rod having a clamp module disposed at a first end of the rod and including a first clamp body, a second clamp body, and a clamp support; an X-ray emission module; an X-ray sensing module; and a manipulation module, in which the rod is inserted into the human body, X-rays are emitted from the X-ray emission module with the first end of the first clamp body and the first end of the second clamp body open with a lesion positioned therebetween in the human body, and the X-rays travel through the lesion and is then sensed by the X-ray sensing module.Type: ApplicationFiled: October 5, 2023Publication date: January 25, 2024Applicants: Korea University Research and Business Foundation, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATIONInventors: Hyun-Koo KIM, Jae-Sung LEE
-
Publication number: 20240018262Abstract: An antibody specific to GPC3 (Glypican 3) and uses thereof, and more particularly, to an antibody that specifically binds to GPC3, a chimeric antigen receptor comprising the antibody, a CAR-T cell expressing the chimeric antigen receptor, and a pharmaceutical composition for preventing or treating diseases mediated by cells expressing GPC3 comprising the same are provided. Antibodies that more specifically bound to GPC3 were screened to establish six novel antibodies (10E9, 8B2, 7C6, 7B9, 5E11, 1A8), and it was confirmed that the novel antibodies specifically bound to GPC3 antigen. Since it was confirmed that GPC3-CAR-T cells prepared in the present invention effectively recognized the GPC3 antigen, induced activation of the CAR-T cells, and effectively killed cells expressing GPC3, GPC3-specific antibody of the present invention, the chimeric antigen receptor prepared using the same and CAR-T cell(s) can be applied to the prevention or treatment of cancers or tumors expressing GPC3.Type: ApplicationFiled: December 7, 2021Publication date: January 18, 2024Applicant: INNOBATION BIO., LTD.Inventors: Ki Tae KIM, Seung Koo KIM
-
Patent number: 11874746Abstract: Technologies are described for facilitating database system recovery in a distributed database environment having a master node and at least one slave node. The master node maintains an in-memory reference that includes transaction identifiers and their corresponding commit identifiers. When a slave node requests that a commit identifier be assigned to a transaction, the transaction and commit identifiers for the transaction are added to the in-memory reference. The commit identifier is sent by the master node to the slave node. The slave node writes a log entry to a commit log that includes the transaction identifier and the assigned commit identifier. If the database system is interrupted before the slave node writes the commit log entry, the slave node can request the commit identifier for the transaction from the master node, which retrieves the identifier from the in-memory reference.Type: GrantFiled: July 30, 2020Date of Patent: January 16, 2024Assignee: SAP SEInventors: Christian Bensberg, Steffen Geissinger, Juchang Lee, Chang Gyoo Park, Kyu Hwan Kim, Deok Koo Kim
-
Patent number: 11876229Abstract: Disclosed is a negative electrode including: a current collector; a negative electrode active material layer disposed on at least one surface of the current collector, including a silicon-based active material and a conductive material, and containing no binder polymer; and a coating layer disposed on the surface of the negative electrode active material layer and in at least a part of the inside of the pores of the negative electrode active material layer, and containing a coating layer polymer forming a chemical bond with silicon (Si) of the silicon-based active material, wherein the content of the coating layer polymer is 0.3-2 parts by weight based on 100 parts by weight of the negative electrode active material layer, and the coating layer polymer is a mixture of polyacrylic acid with polyvinyl alcohol.Type: GrantFiled: January 28, 2020Date of Patent: January 16, 2024Assignee: LG Energy Solution, Ltd.Inventors: Ji-Won Min, Seok-Koo Kim, Joon Kwon, Sun-Kyu Kim, Ju-Ri Kim, Kyung-Eun Sun
-
Publication number: 20240006186Abstract: Disclosed is a plasma etching method. The method includes a first step of vaporizing liquid heptafluoropropyl methyl ether (HFE-347mcc3) and liquid pentafluoropropanol (PFP); a second step of supplying a discharge gas containing the vaporized HFE-347mcc3, the vaporized PFP, and argon gas to a plasma chamber in which an etching target is disposed; and a third step of discharging the discharge gas to generate plasma and of plasma-etching the etching target using the generated plasma.Type: ApplicationFiled: July 28, 2021Publication date: January 4, 2024Applicant: Ajou University Industry-Academic Cooperation FoundationInventors: Chang-Koo KIM, Jun-Hyun KIM, Sang-Hyun YOU
-
Patent number: 11856201Abstract: A method of determining a reference picture set (RPS), which is a set of reference pictures used in predictive decoding of a current picture that is to be decoded includes: obtaining a flag indicating whether the RPS is determined based on picture order count (POC) values of the current picture and a previous picture or whether the RPS is determined based on an index of a reference RPS, which is an identification value of the reference RPS that is one of pre-defined RPSs and is referred to in determining the RPS, and a delta RPS that is a difference value between a POC vale of a reference picture included in the reference RPS and a POC value of a reference picture included in the RPS; and determining the RPS according to a value of the flag.Type: GrantFiled: September 29, 2022Date of Patent: December 26, 2023Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Il-koo Kim, Young-o Park
-
Publication number: 20230411688Abstract: An electrolyte for a lithium secondary battery including a wettability-improving additive having a trifluoromethylsulfonyl group. The electrolyte has reduced surface tension to improve the wettability of an electrode assembly with the electrolyte. Therefore, it is possible to ensure high electrolyte wettability even when the electrolyte includes a high-boiling point solvent or a high concentration of lithium salt.Type: ApplicationFiled: November 30, 2021Publication date: December 21, 2023Inventors: Jeong-Beom LEE, Ye-Eun KIM, Seok-Koo KIM, Je-Young KIM
-
Patent number: 11819349Abstract: The present invention relates to an X-ray imaging device for minimally invasive surgery, the device including: a rod having a clamp module disposed at a first end of the rod and including a first clamp body, a second clamp body, and a clamp support; an X-ray emission module; an X-ray sensing module; and a manipulation module, in which the rod is inserted into the human body, X-rays are emitted from the X-ray emission module with the first end of the first clamp body and the first end of the second clamp body open with a lesion positioned therebetween in the human body, and the X-rays travel through the lesion and is then sensed by the X-ray sensing module.Type: GrantFiled: May 9, 2016Date of Patent: November 21, 2023Assignees: Korea University Research and Business Foundation, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATIONInventors: Hyun-Koo Kim, Jae-Sung Lee
-
Publication number: 20230365686Abstract: The present invention relates to a humanized antibody specific for CD22 and a chimeric antigen receptor using the same, and more specifically, to a humanized antibody specifically binding to CD22, a chimeric antigen receptor including the antibody, a CAR-T cell expressing the chimeric antigen receptor, a pharmaceutical composition including the same and a method for preventing or treating a disease mediated by B cells using the pharmaceutical composition. In the present invention, it was confirmed that the CD22-CAR-T cells prepared based on a humanized antibody specifically binding to CD22 effectively recognized a CD22 antigen to activate CAR-T cells, and that the CD22-CAR-T cells effectively killed cells expressing CD22. Furthermore, the humanized antibody-based CD22-CAR-T cells specifically binding to CD22 of the present invention can be usefully utilized as a composition for preventing or treating a disease related to the expression of CD22 or a disease related to B cells.Type: ApplicationFiled: June 20, 2023Publication date: November 16, 2023Applicant: InnoBation Bio Co., Ltd.Inventors: Seung Koo KIM, Ki Tae KIM
-
Publication number: 20230352737Abstract: A non-aqueous electrolyte for a lithium secondary battery and a lithium secondary battery including the same are provided. The non-aqueous electrolyte includes a compound represented by the following formula, R1-O—CH2—R2, in an amount of 2 wt % to 50 wt % based on a total weight of the non-aqueous electrolyte, an organic solvent containing a nitrile-based solvent in an amount of 90 vol % to 100 vol %, and a lithium salt.Type: ApplicationFiled: October 13, 2021Publication date: November 2, 2023Inventors: Jeong Beom Lee, Ye Eun Kim, Je Young Kim, Seok Koo Kim
-
Patent number: 11804635Abstract: A separator comprising a crosslinked polyolefin substrate having a plurality of pores and an inorganic coating layer having internal pores formed on at least one surface of the crosslinked polyolefin substrate. The inorganic coating layer on the at least one surface of the crosslinked polyolefin substrate has internal pores formed by an immersion phase separation method, and a high power secondary battery including the same.Type: GrantFiled: October 30, 2019Date of Patent: October 31, 2023Assignee: LG ENERGY SOLUTION, LTD.Inventors: Su Rim Lee, Soon Hyung Choi, Seok Koo Kim